Frost Radar：2025 年北美 CDI

Frost Radar: Clinical Documentation Integrity in North America, 2025

出版日期: 2025年04月23日 | 出版商:

Frost & Sullivan | 英文 25 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

基準化分析系統激勵主要企業－創新推動新的交易流程和成長管道

隨著醫療產業從 FFS 模式轉變為 FFV 模式，基於價值的薪酬正在成為 ACO、獨立醫師執業和非 ACO營業單位的標準。這一轉變凸顯了 CDI 專家、醫療編碼員和利用管理人員在增強個人化護理、減少藥物調節錯誤等不利事件以及提高報銷效率方面的重要作用。

CDI 是收益週期管理的一個組成部分，是醫療保健領域的策略必要事項，其角色不僅限於索賠處理和拒賠管理。 CDI 改善了患者的治療效果，確保了數據準確性，反映了真實的護理場景，支持了準確的報銷，並增強了合規風險管理和收益完整性。

隨著新時代 CDI 供應商優先採用會話式 AI、醫療編碼中的 AI 臨床助理、臨床文件中的環境AI 以及自主編碼中的機器學習和自然語言處理等最尖端科技，基於電子健康記錄和傳統 CDI 提供者必須保持競爭力並重新定義臨床文件工具，以支援整體醫療保健領域的下一代工作流程。

Frost & Sullivan 分析了某個行業內的大量公司。 Frost & Sullivan 對該行業內的眾多公司進行分析，根據領導力或其他卓越表現選擇這些公司進行進一步分析，根據 10 個「成長」和「創新」標準對它們進行基準測試，並揭示它們在 Frost Radar(TM) 上的排名。它為 Frost Radar(TM) 上列出的每家公司提供了競爭概況，並討論了每家公司的優勢以及最適合這些優勢的商業機會。

As the healthcare industry shifts from a fee-for-service to a fee-for-value model, value-based reimbursement is becoming the standard for accountable care organizations (ACOs), independent physician practices, and non-ACO entities. This transition underscores the essential role of clinical documentation integrity (CDI) specialists, medical coders, and utilization management staff in enhancing care personalization; mitigating adverse events, such as medication reconciliation errors; and improving reimbursement efficiency.

CDI, which is an integral part of revenue cycle management, is a strategic imperative in healthcare, extending beyond its role in claims processing and denials management. It enhances patient outcomes, ensures data accuracy to reflect the true care narrative, supports precise reimbursement, and strengthens compliance risk management and revenue integrity.

As new-age CDI vendors prioritize the adoption of cutting-edge technology, such as conversational AI, AI clinical assistant in medical coding, and the use of ambient AI in clinical documentation and machine learning and natural language processing in autonomous coding, it has become imperative for electronic health record-based and legacy CDI providers to stay competitive and redefine their clinical documentation tools to support next-generation workflows across the healthcare continuum.

Frost & Sullivan analyzes numerous companies in an industry. Those selected for further analysis based on their leadership or other distinctions are benchmarked across 10 Growth and Innovation criteria to reveal their position on the Frost Radar™. The publication presents competitive profiles of each company on the Frost Radar™ considering their strengths and the opportunities that best fit those strengths.